Trial results for new lung cancer drug are off the charts', say doctors
A new drug, lorlatinib, has shown unprecedented success in stopping lung cancer progression, leading to a longer survival rate compared to standard treatment. [ more ]
Dr. Subbiah focuses on ensuring that every person has access to cancer clinical trials, regardless of their background or location.
Expanding access to clinical trials represents a paradigm shift in oncology, and convincing stakeholders of the value of equitable representation is a challenge for Dr. Subbiah. [ more ]
WHO says we can 'write the final chapter in the story of TB.' How close are we?
The head of the World Health Organization wants to eradicate tuberculosis, one of the oldest and deadliest diseases.
Two clinical trials have shown that taking levofloxacin, an antibiotic commonly used for drug-resistant TB, can reduce the risk of developing drug-resistant strains by about 60%.
The new data could inform global TB guidelines in the future. [ more ]
WHO says we can 'write the final chapter in the story of TB.' How close are we?
The head of the World Health Organization wants to eradicate tuberculosis, one of the oldest and deadliest diseases.
Two clinical trials have shown that taking levofloxacin, an antibiotic commonly used for drug-resistant TB, can reduce the risk of developing drug-resistant strains by about 60%.
The new data could inform global TB guidelines in the future. [ more ]
She survived stomach cancer. Now, she's helping fight the deadly disease | CBC News
Katy Kosyachkova was diagnosed with stomach cancer over a decade ago and founded My Gut Feeling to support stomach cancer patients and survivors.
Only 29% of those diagnosed with gastroesophageal (GE) cancers survive for at least five years, highlighting the need for advocacy and support.
My Gut Feeling has helped secure millions in grant money for research on gastroesophageal cancers, including funding for clinical trials of a promising drug. [ more ]
She survived stomach cancer. Now, she's helping fight the deadly disease | CBC News
Katy Kosyachkova was diagnosed with stomach cancer over a decade ago and founded My Gut Feeling to support stomach cancer patients and survivors.
Only 29% of those diagnosed with gastroesophageal (GE) cancers survive for at least five years, highlighting the need for advocacy and support.
My Gut Feeling has helped secure millions in grant money for research on gastroesophageal cancers, including funding for clinical trials of a promising drug. [ more ]
Guest Post: Jillian Grennan, Charting New Paths in Innovation: Reflections from Harvard's Innovation Economics Conference
(Editor's note: (This post is part of a series by the Diversity Pilots Initiative, which advances inclusive innovation through rigorous research.The first blog in the series is here, and resources from the first conference of the initiative are available here.-Jason) By: Jillian Grennan, Associate Professor of Finance and Principal, Diversity Pilots Initiative Recently, I had the privilege of being part of the Junior Innovation Economics Conference at Harvard Business School.